Y10S514/863 - CPC Classification Index

#1

20170128452

2017-05-11

Aminopterin dosage forms

#2

20150064197

2015-03-05

Methods of modulating immunity

#3

20140271626

2014-09-18

Mutated anti-TNFα antibodies and methods of their use

#4

20120329835

2012-12-27

USE OF 1-HYDROXY-2- PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITIS

#5

20120308514

2012-12-06

Human antibodies that bind human interleukin-12

#6

20120270901

2012-10-25

Indene derivatives as pharmaceutical agents

#7

20120263810

2012-10-18

Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques

#8

20120244168

2012-09-27

Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same

#9

20120213792

2012-08-23

Methods of treatment using human antibodies that bind IL-12

#10

20120165301

2012-06-28

BENZODIAZEPINE COMPOSITIONS FOR TREATING EPIDERMAL HYPERPLASIA AND RELATED DISORDERS

#11

20120135933

2012-05-31

Soluble tumor necrosis factor receptor treatment of medical disorders

#12

20120128703

2012-05-24

Aminopterin Dosage Forms and Methods for Inflammatory Disorders

#13

20120087873

2012-04-12

Urea foam

#14

20120070384

2012-03-22

Topical antifungal composition

#15

20110269801

2011-11-03

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

#16

20110251146

2011-10-13

TOPICAL ANTIFUNGAL COMPOSITION

#17

20110172258

2011-07-14

INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS

#18

20110165177

2011-07-07

Methods of Modulating Immunity

#19

20110142832

2011-06-16

Soluble tumor necrosis factor receptor treatment of medical disorders

#20

20110112153

2011-05-12

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

#21

20110112150

2011-05-12

USE OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITIS

#22

20110014306

2011-01-20

Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques

#23

20110009439

2011-01-13

Indene derivatives as pharmaceutical agents

#24

20100222310

2010-09-02

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

#25

20100173881

2010-07-08

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#26

20100152220

2010-06-17

Indene derivatives as pharmaceutical agents

#27

20100098677

2010-04-22

Methods and devices for epithelial protection during photodynamic therapy

#28

20100087403

2010-04-08

Topical treatment of skin infection

#29

20100076031

2010-03-25

USE OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITIS

#30

20090286871

2009-11-19

Use of a plant oil product as an agent for increasing the synthesis of skin lipids

#31

20090269302

2009-10-29

HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING

#32

20090175857

2009-07-09

Human Antibodies That Bind Human IL-12 And Methods For Producing

#33

20090163424

2009-06-25

Soluble tumor necrosis factor receptor treatment of medical disorders

#34

20090149473

2009-06-11

Topical antifungal composition

#35

20090131340

2009-05-21

USE OF FLAVONOIDS AS IMMUNOMODULATING OR IMMUNO-PROTECTIVE AGENTS IN COSMETIC AND DERMATOLOGICAL PREPARATIONS

#36

20090060940

2009-03-05

Compositions and methods for treating psoriasis by (Reishi) polysaccharides

#37

20080305114

2008-12-11

HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING

#38

20080280863

2008-11-13

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#39

20080269203

2008-10-30

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

#40

20080175793

2008-07-24

Urea foam

#41

20080170997

2008-07-17

Compositions for the treatment and prevention of cancer

#42

20080146531

2008-06-19

Therapeutically active triazoles and their use

#43

20080108621

2008-05-08

Aminopterin dosage forms and methods for inflammatory disorders

#44

20080096893

2008-04-24

AMINOPTERIN DOSAGE FORMS

#45

20080032956

2008-02-07

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

#46

20080003279

2008-01-03

Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing

#47

20070269508

2007-11-22

Coenzyme Q10 Formulation and Process Methodology for Soft Gel Capsules Manufacturing

#48

20070088008

2007-04-19

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

#49

20070059253

2007-03-15

Foamable pharmaceutical compositions and methods for treating a disorder

#50

20060269625

2006-11-30

Methods of inhibiting proliferation of cells

#51

20060205729

2006-09-14

Aminopterin dosage forms and methods for inflammatory disorders

#52

20060199784

2006-09-07

Compound selected from sulfated cellulose and salts thereof and dermatitis therapeutic agent

#53

20060183729

2006-08-17

Vanadium compounds as anti-angiogenic agents

#54

20060183727

2006-08-17

Estrogenic compounds as anti-mitotic agents

#55

20060088561

2006-04-27

Pharmaceutical composition for topical application

#56

20060084701

2006-04-20

Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy

#57

20060084107

2006-04-20

Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction

#58

20060025388

2006-02-02

Compositions and methods relating to novel compounds and targets thereof

#59

20060020020

2006-01-26

Regulators of the hedgehog pathway, compositions and uses related thereto

#60

20060018958

2006-01-26

Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing

#61

20060009380

2006-01-12

Isolated polypeptide of the stratum corneum and its use

#62

20050282789

2005-12-22

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

#63

20050239724

2005-10-27

Skin penetration enhancing components

#64

20050196395

2005-09-08

Methods of modulating immunity

#65

20050106228

2005-05-19

Compositions for the treatment and prevention of cancer

#66

20050089485

2005-04-28

Sulfacetamide formulations for treatment of rosacea

#67

20050084458

2005-04-21

Compositions for the treatment and prevention of cancer

#68

20050043281

2005-02-24

2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds

#69

20050004354

2005-01-06

Human antibodies that bind human IL-12

#70

20050004086

2005-01-06

Indene derivatives as pharmaceutical agents